Written by
Mustafa Çelik
Mustafa Çelik Liv Hospital Content Team
Medically reviewed by

Related Doctors

Assoc. Prof. MD. Evrim Duman Liv Hospital Ulus Assoc. Prof. MD. Evrim Duman Radiation Oncology Asst. Prof. MD. Meltem Topalgökçeli Selam Liv Hospital Ulus Asst. Prof. MD. Meltem Topalgökçeli Selam Medical Oncology Prof. MD. Duygu Derin Liv Hospital Ulus Prof. MD. Duygu Derin Medical Oncology Prof. MD. Emre Merdan Fayda Liv Hospital Ulus Prof. MD. Emre Merdan Fayda Radiation Oncology Prof. MD. Meral Günaldı Liv Hospital Ulus Prof. MD. Meral Günaldı Medical Oncology Assoc. Prof. MD. Murat Ayhan Liv Hospital Vadistanbul Assoc. Prof. MD. Murat Ayhan Medical Oncology Prof. MD.  Itır Şirinoğlu Demiriz Liv Hospital Vadistanbul Prof. MD. Itır Şirinoğlu Demiriz Hematology Prof. MD. Tülin Tıraje Celkan Liv Hospital Vadistanbul Prof. MD. Tülin Tıraje Celkan Pediatric Hematology and Oncology Assoc. Prof. MD. Erkan Kayıkçıoğlu Liv Hospital Bahçeşehir Assoc. Prof. MD. Erkan Kayıkçıoğlu Medical Oncology Assoc. Prof. MD. Mine Dağgez Liv Hospital Bahçeşehir Assoc. Prof. MD. Mine Dağgez Gynecological Oncology Assoc. Prof. MD. Ozan Balakan Liv Hospital Bahçeşehir Assoc. Prof. MD. Ozan Balakan Medical Oncology MD. Taylan Bükülmez Liv Hospital Bahçeşehir MD. Taylan Bükülmez Radiation Oncology Op. MD. Alp Koray Kinter Liv Hospital Bahçeşehir Op. MD. Alp Koray Kinter Gynecological Oncology Prof. MD. Nuri Faruk Aykan Liv Hospital Bahçeşehir Prof. MD. Nuri Faruk Aykan Medical Oncology Spec. MD. Özlem Doğan Liv Hospital Bahçeşehir Spec. MD. Özlem Doğan Medical Oncology Assoc. Prof. MD. Emir Çelik Liv Hospital Topkapı Assoc. Prof. MD. Emir Çelik Medical Oncology Assoc. Prof. MD. Muhammed Mustafa Atcı Liv Hospital Topkapı Assoc. Prof. MD. Muhammed Mustafa Atcı Medical Oncology Prof. MD. İrfan Çiçin Liv Hospital Topkapı Prof. MD. İrfan Çiçin Medical Oncology Assoc. Prof. MD.  Ramazan Öcal Liv Hospital Ankara Assoc. Prof. MD. Ramazan Öcal Hematology Assoc. Prof. MD. Nazlı Topfedaisi Özkan Liv Hospital Ankara Assoc. Prof. MD. Nazlı Topfedaisi Özkan Gynecological Oncology Prof. MD. Fikret Arpacı Liv Hospital Ankara Prof. MD. Fikret Arpacı Medical Oncology Prof. MD. Gökhan Erdem Liv Hospital Ankara Prof. MD. Gökhan Erdem Medical Oncology Prof. MD. Meral Beksaç Liv Hospital Ankara Prof. MD. Meral Beksaç Hematology Prof. MD. Oral Nevruz Liv Hospital Ankara Prof. MD. Oral Nevruz Hematology Prof. MD. Saadettin Kılıçkap Liv Hospital Ankara Prof. MD. Saadettin Kılıçkap Medical Oncology Prof. MD. Sadık Muallaoğlu Liv Hospital Ankara Prof. MD. Sadık Muallaoğlu Medical Oncology Spec. MD. Ender Kalacı Liv Hospital Ankara Spec. MD. Ender Kalacı Medical Oncology Assoc. Prof. MD. Fadime Ersoy Dursun Liv Hospital Gaziantep Assoc. Prof. MD. Fadime Ersoy Dursun Hematology Prof. MD. Fatih Teker Liv Hospital Gaziantep Prof. MD. Fatih Teker Medical Oncology Spec. MD. ELXAN MEMMEDOV Liv Bona Dea Hospital Bakü Spec. MD. ELXAN MEMMEDOV Medical Oncology Spec. MD. Ceyda Aslan Spec. MD. Ceyda Aslan Hematology Spec. MD. Elkhan Mammadov Spec. MD. Elkhan Mammadov Medical Oncology Spec. MD. Elmir İsrafilov Spec. MD. Elmir İsrafilov Hematology Spec. MD. Minure Abışova Eliyeva Spec. MD. Minure Abışova Eliyeva Hematology Spec. MD. Natavan Azizova Spec. MD. Natavan Azizova Medical Oncology Prof. MD. Mehmet Hilmi Doğu Liv Hospital Ulus + Liv Hospital Bahçeşehir Prof. MD. Mehmet Hilmi Doğu Hematology
...
Views
Read Time
...
views
Read Time

Sep-14133-What is the difference between a FDG PET scan and a Dotatate PET scan?

Dotatate Pet Scan: Better Than Fdg Imaging
Dotatate Pet Scan: Better Than Fdg Imaging 4

Diagnosing and managing cancer, like neuroendocrine tumors, depends a lot on the imaging test used. PET scans are key, but not all are the same. FDG PET and Dotatate PET scans are different, each with its own uses.

FDG PET scans use 18F-fluorodeoxyglucose to spot areas with high glucose use, common in many cancers. Dotatate PET scans, on the other hand, use 68Ga-DOTATATE to find neuroendocrine tumors (NETs). This makes Dotatate PET a great tool for diagnosing and staging NETs.

Studies have found that Dotatate PET is more sensitive and shows better contrast. This helps doctors make more accurate diagnoses, mainly for NETs. Knowing the differences between these scans is key for choosing the right test for cancer patients.

Key Takeaways

  • FDG PET scans are generally used for most cancers due to their ability to highlight increased glucose metabolism.
  • Dotatate PET scans are used for neuroendocrine tumors because they bind to somatostatin receptors.
  • Dotatate PET has shown higher sensitivity and diagnostic confidence in NET staging and detection.
  • The choice between FDG PET and Dotatate PET depends on the specific type of cancer and its characteristics.
  • Understanding the strengths of each PET scan type is essential for accurate diagnosis and effective treatment planning.

Understanding PET Scan Technology

Dotatate Pet Scan: Better Than Fdg Imaging
Dotatate Pet Scan: Better Than Fdg Imaging 5

PET scan technology has changed how we see inside the body. It uses small amounts of radioactive tracers to help find and track diseases, like cancer. This method is key in diagnosing and monitoring health issues.

Basic Principles of PET Imaging

PET imaging works by catching gamma rays from a radiotracer. This tracer goes to areas with lots of activity, like tumors. The PET scanner then shows these rays, giving us clear images of the body’s inside.

Role of Radiotracers in Diagnostic Imaging

Radiotracers are vital in imaging because they show us specific body processes. Different tracers, like FDG and Dotatate, help doctors see different activities. This helps in diagnosing and tracking many health conditions.

FDG PET Scan: Mechanism and Function

Dotatate Pet Scan: Better Than Fdg Imaging
Dotatate Pet Scan: Better Than Fdg Imaging 6

FDG PET scans use 18F-fluorodeoxyglucose to look at how cells use glucose. This helps find and track cancer. It works because 18F-fluorodeoxyglucose acts like glucose in cells.

How 18F-fluorodeoxyglucose Works in the Body

18F-fluorodeoxyglucose is a special sugar that cells take in. It gets stuck in cells because of a chemical reaction. Cancer cells take in more of it because they grow fast.

Glucose Metabolism as a Cancer Marker

Cancer cells use more glucose because they grow quickly. The FDG PET scan spots these areas. It does this by showing where 18F-fluorodeoxyglucose is taken in.

Standard Uptake Values and Interpretation

FDG PET scans use Standard Uptake Values (SUVs) to measure glucose use. High SUVs mean cells are very active, often a sign of cancer. Doctors use these values to see how serious the cancer is and if treatments are working.

A top oncologist says, “FDG PET scans have changed how we fight cancer. They give us a key tool in the battle against this disease.”

“FDG PET scans are essential in cancer care. They give deep insights into cancer’s metabolism and help make treatment plans.”

Dotatate PET Scan: The Specialized Imaging Option

The Dotatate PET scan uses 68Ga-DOTATATE to show how neuroendocrine tumors work. It targets somatostatin receptors, which are common in these tumors.

How 68Ga-DOTATATE Works in the Body

The 68Ga-DOTATATE binds to somatostatin receptors on tumor cells. This helps doctors find and understand NETs better.

Somatostatin Receptor Targeting

68Ga-DOTATATE is very good at finding tumors with somatostatin receptors. This is key for spotting small NETs and seeing how far they’ve spread.

Uptake Patterns and Interpretation

Doctors look at how 68Ga-DOTATATE is taken up by tumors. High uptake means tumors are present. They use this info to check how well treatments are working and make plans.

Studies show Dotatate PET scans are very good at finding NETs. This makes them very useful in medical care.

Key Differences in Tracer Properties and Behavior

FDG and Dotatate tracers have different chemical structures, biological distributions, and half-lives. These differences affect how well they work for diagnosis. Knowing these differences helps choose the right PET scan for each case.

Chemical Structure Comparison

FDG and Dotatate are made differently. FDG acts like glucose and is taken up by cells that use a lot of glucose. Dotatate targets somatostatin receptors, found in certain tumors.

Biological Distribution Patterns

FDG goes to areas with lots of activity, like cancer. Dotatate finds tumors that have somatostatin receptors.

Tracer

Chemical Structure

Biological Distribution

FDG

Glucose analog

High metabolic areas

Dotatate

Somatostatin receptor-targeting

Neuroendocrine tumors

Half-life and Imaging Window Differences

FDG and Dotatate have different half-lives. This affects how long they can be used for imaging. Knowing this helps plan imaging and understand results better.

Understanding FDG and Dotatate’s unique traits helps doctors choose the best PET scan for each patient.

Clinical Applications of FDG PET Scans

FDG PET scan technology is key in clinical oncology. It helps detect and manage different cancers. This is because it shows detailed metabolic info about tumors.

Common Cancer Types Effectively Detected

FDG PET scans work well on cancers with high metabolic rates. This includes lymphomas, lung cancer, and some breast cancers. They help in cancer staging, seeing how far it has spread, and checking treatment results.

Sensitivity and Specificity Rates

FDG PET scans are good at finding cancer, with a sensitivity of about 75%. This means they’re good at spotting true positives. The specificity is around 80%, showing they can rule out cancer in those without it. But, these numbers can change based on the cancer type and other factors.

Limitations in Slow-Growing Tumors

FDG PET scans have their limits, mainly with slow-growing or low-metabolic tumors. For example, well-differentiated neuroendocrine tumors might be harder to spot because they don’t take up much glucose. This shows we need other imaging methods in some cases.

Knowing what FDG PET scans can and can’t do helps us use them better. This can lead to better cancer diagnosis and treatment, improving patient care.

Clinical Applications of Dotatate PET Scan Technology

Dotatate PET scans have shown great promise in diagnosing and managing neuroendocrine tumors. This technology is a valuable tool in nuclear medicine. It offers high sensitivity and specificity in detecting these complex tumors.

Neuroendocrine Tumor Detection Excellence

Dotatate PET scans are excellent at detecting neuroendocrine tumors (NETs). The 68Ga-DOTATATE binds to somatostatin receptors in NETs. This allows for precise localization and staging of these tumors. It has greatly improved diagnostic workup and treatment planning for patients with NETs.

Superior Sensitivity in NET Imaging

Studies show Dotatate PET scans have superior sensitivity in NET imaging. A study in Nature found Dotatate PET scans are more sensitive than traditional imaging. This high sensitivity is key for early detection and accurate staging, which impacts treatment decisions.

Applications Beyond Traditional NETs

Research suggests Dotatate PET scans may be used for more than just traditional NETs. Studies are exploring its use in diagnosing and managing other tumors that express somatostatin receptors. This growing role of Dotatate PET scans highlights their versatility and impact on oncology.

Clinical Application

Benefits

Future Directions

Neuroendocrine Tumor Detection

High sensitivity and specificity, improved diagnostic accuracy

Enhanced treatment planning and patient outcomes

NET Imaging

Superior sensitivity compared to conventional imaging

Potential for earlier detection and intervention

Beyond Traditional NETs

Potential applications in other somatostatin receptor-positive tumors

Ongoing research and expanding clinical utility

Comparative Effectiveness in Cancer Detection

It’s important to know how FDG and Dotatate PET scans compare in cancer detection. Recent studies have looked into this, giving us insights into their strengths and weaknesses.

Head-to-Head Clinical Studies

Several studies have compared FDG and Dotatate PET scans. They found that the type of radiotracer used affects tumor detection. Dotatate PET is better for neuroendocrine tumors, while FDG PET works well for many other cancers.

Lesion-to-Background Contrast Comparison

The contrast between tumors and background is key in PET scans. Dotatate PET often shows better contrast for neuroendocrine tumors. This makes diagnoses more accurate and detailed.

Impact on Diagnostic Confidence

Dotatate PET’s better contrast can boost doctor confidence in diagnoses. When doctors are more confident, treatment plans are better, and patients do better. The choice between FDG and Dotatate PET scans affects not just detection but the whole treatment process.

Organ-Specific Detection Capabilities

FDG and Dotatate PET scans work differently for finding cancer in various organs. This is key for picking the right scan for each cancer type.

Bone Metastases Detection

FDG PET scans are better at finding cancer in bones than Dotatate PET scans. They have a 97.8% detection rate, while Dotatate has a 84.4% rate.

Liver Metastases Detection Differences

Dotatate PET scans are great for finding cancer in the liver, mainly for neuroendocrine tumors. On the other hand, FDG PET scans work well for many types of cancer.

Other Organ Systems Performance

FDG and Dotatate PET scans perform differently in other organs like the lungs and lymph nodes. This depends on the type of cancer and the radiotracer used.

Organ

FDG PET Scan Sensitivity

Dotatate PET Scan Sensitivity

Bone

97.8%

84.4%

Liver

85.6%

92.1%

Patient Preparation and Procedure Differences

FDG and Dotatate PET scans are different in many ways. This includes how patients prepare and the procedures they go through. It’s important for patients to know these differences to prepare well for their scans.

Pre-Scan Requirements and Restrictions

Before a PET scan, patients must follow certain rules. For FDG PET scans, they usually need to fast for a few hours and avoid hard exercise. On the other hand, Dotatate PET scans might have different rules, like stopping certain medicines that could mess up the scan.

Procedure Duration and Patient Experience

The time it takes for both FDG and Dotatate PET scans is about 30 minutes to an hour for the scan itself. But the whole process, including getting ready and being in the scanning room, can take several hours. Patients might feel a bit uncomfortable because they have to stay very quiet during the scan.

Radiation Exposure Considerations

Both FDG and Dotatate PET scans use radiation. But the amount and kind of radiation are different because of the radiotracers used. We think about these differences when choosing the best scan for a patient. We aim to find the right balance between getting good information and keeping the risks from radiation low.

Combined Use of FDG and Dotatate PET Scans

Using FDG and Dotatate PET scans together gives a deeper look at complex cases. This combined approach uses the best of both scans. It paints a clearer picture of a patient’s health.

Complementary Information for Complex Cases

The complementary information from both scans is very useful for complex or rare conditions. FDG PET scans are great at finding tumors that are active. Dotatate PET scans, on the other hand, are very good at finding neuroendocrine tumors. This is because they stick to somatostatin receptors.

Impact on Treatment Planning and Prognosis

The use of both FDG and Dotatate PET scans changes treatment planning a lot. It gives a detailed look at how far the disease has spread. This helps doctors make better decisions and improves the patient’s outlook.

Studies, like those on PubMed Central, show that using more than one PET tracer can make diagnosis more accurate.

Current Research on Dual-Tracer Approaches

Research is ongoing to see how much dual-tracer approaches can help. Scientists are looking into how using FDG and Dotatate PET scans together can improve treatment plans. They want to learn more about its benefits and limits.

Cost, Insurance Coverage, and Availability Considerations

When choosing between FDG and Dotatate PET scans, cost and insurance are big factors. It’s important for patients and doctors to understand these aspects well.

Comparative Costs Between Scan Types

The prices of FDG and Dotatate PET scans can change a lot. This depends on where you get the scan, where you are, and the details of the scan.

Both scans usually cost about the same. But Dotatate scans might be a bit pricier. This is because of the newer tech and the special tracer used.

Insurance Coverage Landscape

How insurance covers PET scans can differ a lot. Most plans cover FDG scans for some cancers. Dotatate scans are getting more coverage, mainly for neuroendocrine tumors.

“Insurance coverage for advanced diagnostic imaging like PET scans is key for patient access to these life-saving technologies.”

Nuclear Medicine Expert

Accessibility in Different Healthcare Settings

Where you can get FDG and Dotatate PET scans varies. Big cancer centers and specialized hospitals often have both. But smaller or rural places might not.

Scan Type

Average Cost

Insurance Coverage

Accessibility

FDG PET Scan

$1,000 – $3,000

Widely covered for various cancers

High

Dotatate PET Scan

$1,200 – $3,500

Increasingly covered, mainly for NETs

Moderate to High

Conclusion: Selecting the Appropriate PET Scan for Optimal Diagnosis

Choosing the right PET scan is key for the best diagnosis and treatment plans. We’ve looked at how FDG PET scans and Dotatate PET scans differ. Each has its own strengths and uses in medicine.

Which scan to use depends on the patient’s situation. Dotatate PET/CT is great for neuroendocrine tumors. It’s very good at finding these tumors.

Doctors need to know the good and bad of each scan. This helps them make better choices. It leads to more accurate diagnoses and treatments. It’s all about finding the best scan for each patient.

PET scans will play an even bigger role in medicine as we learn more. This means we need to keep studying and learning about them.

FAQ

What is the main difference between a FDG PET scan and a Dotatate PET scan?

FDG PET scans use 18F-fluorodeoxyglucose to show where glucose is used more, like in many cancers. Dotatate PET scans use 68Ga-DOTATATE to find neuroendocrine tumors. This is because these tumors often have more somatostatin receptors.

How does a PET scan work?

PET scans use tiny amounts of radioactive tracers. These tracers are injected into the body. They gather in specific areas, like tumors, for detailed images.

What is the role of radiotracers in PET imaging?

Radiotracers are key in PET imaging. They go to specific areas, like tumors, to show metabolic processes. Different tracers target different processes, making them useful for diagnosing many conditions.

What are the clinical applications of FDG PET scans?

FDG PET scans are used to find and track many cancers. They work because cancer cells use more glucose. This makes them great for seeing how far cancer has spread and how well treatments are working.

What are the advantages of Dotatate PET scans in detecting neuroendocrine tumors?

Dotatate PET scans are better at finding neuroendocrine tumors. They do this because they target somatostatin receptors. This makes them very useful for diagnosing and planning treatment for NETs.

Can FDG and Dotatate PET scans be used together?

Yes, using both FDG and Dotatate PET scans together can give more information. This is helpful in complex cases. It can improve how well treatments are planned and how likely they are to work.

How do patient preparation and procedure differ between FDG and Dotatate PET scans?

The preparation and procedure for FDG and Dotatate PET scans can differ. This includes how patients should prepare, how long the scan takes, and what the experience is like. Knowing these differences helps make the imaging process better.

What are the considerations regarding radiation exposure for PET scans?

Both FDG and Dotatate PET scans use radioactive tracers, which means they involve some radiation. But the doses are safe, and the benefits of getting accurate diagnostic information are usually worth it.

Are there differences in cost and insurance coverage between FDG and Dotatate PET scans?

Yes, the cost and what insurance covers can differ between FDG and Dotatate PET scans. This depends on where you get the scan, your insurance, and the specific situation.

What is the significance of standard uptake values (SUVs) in FDG PET scans?

SUVs in FDG PET scans measure how much tracer is taken up by tissues. They help doctors diagnose and monitor cancer. They also help see how well treatments are working.

How do Dotatate PET scans detect neuroendocrine tumors?

Dotatate PET scans find neuroendocrine tumors by binding to somatostatin receptors. These receptors are often found on the surface of these tumor cells. This specific binding allows for accurate detection and staging of NETs.

What are the emerging applications of Dotatate PET beyond traditional NETs?

Dotatate PET scans are being used for other tumors that have somatostatin receptors. This is expanding their use beyond just traditional neuroendocrine tumors.

References

i

Medical Disclaimer

The content on this page is for informational purposes only and is not a substitute for professional medical advice, diagnosis or treatment. Always consult a qualified healthcare provider regarding any medical conditions.

Book a Free Certified Online
Doctor Consultation

Clinics/branches
GDPR

We're Here to Help.
Get in Touch

Send us all your questions or requests, and our
expert team will assist you.

Our Doctors

Assoc. Prof. MD. Evrim Duman Radiation Oncology

Assoc. Prof. MD. Evrim Duman

Liv Hospital Ulus
Asst. Prof. MD. Meltem Topalgökçeli Selam Medical Oncology

Asst. Prof. MD. Meltem Topalgökçeli Selam

Liv Hospital Ulus
Prof. MD. Duygu Derin Medical Oncology

Prof. MD. Duygu Derin

Liv Hospital Ulus
Prof. MD. Emre Merdan Fayda Radiation Oncology

Prof. MD. Emre Merdan Fayda

Liv Hospital Ulus
Prof. MD. Mehmet Hilmi Doğu Hematology

Prof. MD. Mehmet Hilmi Doğu

Liv Hospital Ulus
Liv Hospital Bahçeşehir
Prof. MD. Meral Günaldı Medical Oncology

Prof. MD. Meral Günaldı

Liv Hospital Ulus
Assoc. Prof. MD. Murat Ayhan Medical Oncology

Assoc. Prof. MD. Murat Ayhan

Liv Hospital Vadistanbul
Prof. MD.  Itır Şirinoğlu Demiriz Hematology

Prof. MD. Itır Şirinoğlu Demiriz

Liv Hospital Vadistanbul
Prof. MD. Tülin Tıraje Celkan Pediatric Hematology and Oncology

Prof. MD. Tülin Tıraje Celkan

Liv Hospital Vadistanbul
Assoc. Prof. MD. Erkan Kayıkçıoğlu Medical Oncology

Assoc. Prof. MD. Erkan Kayıkçıoğlu

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Mine Dağgez Gynecological Oncology

Assoc. Prof. MD. Mine Dağgez

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Ozan Balakan Medical Oncology

Assoc. Prof. MD. Ozan Balakan

Liv Hospital Bahçeşehir
MD. Taylan Bükülmez Radiation Oncology

MD. Taylan Bükülmez

Liv Hospital Bahçeşehir
Op. MD. Alp Koray Kinter Gynecological Oncology

Op. MD. Alp Koray Kinter

Liv Hospital Bahçeşehir
Prof. MD. Nuri Faruk Aykan Medical Oncology

Prof. MD. Nuri Faruk Aykan

Liv Hospital Bahçeşehir
Spec. MD. Özlem Doğan Medical Oncology

Spec. MD. Özlem Doğan

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Emir Çelik Medical Oncology

Assoc. Prof. MD. Emir Çelik

Liv Hospital Topkapı
Assoc. Prof. MD. Muhammed Mustafa Atcı Medical Oncology

Assoc. Prof. MD. Muhammed Mustafa Atcı

Liv Hospital Topkapı
Prof. MD. İrfan Çiçin Medical Oncology

Prof. MD. İrfan Çiçin

Liv Hospital Topkapı
Assoc. Prof. MD.  Ramazan Öcal Hematology

Assoc. Prof. MD. Ramazan Öcal

Liv Hospital Ankara
Assoc. Prof. MD. Nazlı Topfedaisi Özkan Gynecological Oncology

Assoc. Prof. MD. Nazlı Topfedaisi Özkan

Liv Hospital Ankara
Prof. MD. Fikret Arpacı Medical Oncology

Prof. MD. Fikret Arpacı

Liv Hospital Ankara
Prof. MD. Gökhan Erdem Medical Oncology

Prof. MD. Gökhan Erdem

Liv Hospital Ankara
Prof. MD. Meral Beksaç Hematology

Prof. MD. Meral Beksaç

Liv Hospital Ankara
Prof. MD. Oral Nevruz Hematology

Prof. MD. Oral Nevruz

Liv Hospital Ankara
Prof. MD. Saadettin Kılıçkap Medical Oncology

Prof. MD. Saadettin Kılıçkap

Liv Hospital Ankara
Prof. MD. Sadık Muallaoğlu Medical Oncology

Prof. MD. Sadık Muallaoğlu

Liv Hospital Ankara
Spec. MD. Ender Kalacı Medical Oncology

Spec. MD. Ender Kalacı

Liv Hospital Ankara
Assoc. Prof. MD. Fadime Ersoy Dursun Hematology

Assoc. Prof. MD. Fadime Ersoy Dursun

Liv Hospital Gaziantep
Prof. MD. Fatih Teker Medical Oncology

Prof. MD. Fatih Teker

Liv Hospital Gaziantep
Spec. MD. ELXAN MEMMEDOV Medical Oncology

Spec. MD. ELXAN MEMMEDOV

Liv Bona Dea Hospital Bakü
Spec. MD. Ceyda Aslan Hematology

Spec. MD. Ceyda Aslan

Spec. MD. Elkhan Mammadov Medical Oncology

Spec. MD. Elkhan Mammadov

Spec. MD. Elmir İsrafilov Hematology

Spec. MD. Elmir İsrafilov

Spec. MD. Minure Abışova Eliyeva Hematology

Spec. MD. Minure Abışova Eliyeva

Spec. MD. Natavan Azizova Medical Oncology

Spec. MD. Natavan Azizova

Need Help? Chat with our medical team

Let's Talk on WhatsApp

📌

Get instant answers from our medical team. No forms, no waiting — just tap below to start chatting now.

or call us at +90 530 174 42 01